Having followed the company for a number of years, I started buy shares in M7T because I thought FY2025 was finally going to be the year that the Revenue-Cost jaws finally open.
But now it looks like its a FY2026 story. Maybe.
The upwards adjustment to cost expectations is a pity, because it has overshadowed very strong second-half growth, +37%, in Recurring Revenue vs pcp, an acceleration on the first-half's already strong 21% growth vs its pcp.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.030(6.90%) |
Mkt cap ! $95.16M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 39.0¢ | $368.3K | 908.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27889 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 48398 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| M7T (ASX) Chart |